None listed
Conditions
Brief summary
This prospective pilot study will assess various implementation factors associated with integration of a digitally enabled model of care for individuals with type 2 diabetes (T2D) from regional areas into primary care using a digital health intervention. The comprehensive assessment of implementation factors will inform strategies to optimize the implementation process and maximize the effectiveness of future Digital Health interventions.
Interventions
Utilising a smartphone application (available of app stores for free), participants will have the capability to record their blood glucose readings at least once a day and monitor their daily blood glucose levels and receive automated feedback to improve their self-management for a 3-month period. This data will be readily accessible to both a practice nurse and a GP (via an online dashboard) within the local area, facilitating prompt intervention and personalized care. We will be noting the num
Utilising a smartphone application (available of app stores for free), participants will have the capability to record their blood glucose readings at least once a day and monitor their daily blood glucose levels and receive automated feedback to improve their self-management for a 3-month period. This data will be readily accessible to both a practice nurse and a GP (via an online dashboard) within the local area, facilitating prompt intervention and personalized care. We will be noting the number of entries in the dashboard per participant but that is not an outcome of this study. By leveraging technology, the study seeks to bridge the gap in diabetes care for regional populations, offering efficient and accessible monitoring and support. The feedback a participant may be about frequency of blood sugar testing, about diet, exercise, etc. An example would be "Getting 30 minutes of exercise a day can be split into 2x 15-minute sessions- this could be as simple as walking to work, to the shop, or around the block.".
Sponsors
The University of Queensland
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
• T2D, • A glycated haemoglobin (HbA1c) result that is greater than or equal to 8% within the 6 weeks prior to trial consent, • Type 2 diabetes duration for at least 6 months prior to trial consent, • aged greater than equal to 18 years, • currently on insulin for at least 3 months
Exclusion criteria
• do not have a compatible smartphone with wifi / internet access, • unable to communicate (read and write) in English, • use a continuous glucose monitor, • are pregnant or planning to be pregnant, due to the difference in diabetes management, • unstable medical conditions that may impact on diabetes management as determined by the clinician or General Practitioner (for e.g., if they have been on corticosteroids), • has diabetes related medication (including steroids) changes within the last 3 months.
Outcome results
None listed